A recent study from Ontario, Canada, has revealed that Bavarian Nordic A/S’s smallpox vaccine, marketed as Imvamune in Canada and Jynneos in the US, was 58% effective in preventing mpox infections after a single dose.
Trending
- FHFL: Lack of housing data hampers planning in Nigeria
- REDAN president calls for stronger built environment regulation
- FG urges South-South cooperatives to invest in cooperative bank, embrace digital reforms
- NADF urges Africa to build agricultural innovation ecosystems
- FMBN, Surveyor-general say national housing data programme will end conflicting housing figures
- Ex-IGP tasks governors, Almajiri commission on out-of-school children
- MSF calls for greater awareness, prevention of noma
- NAPTIP reaffirms commitment to fighting human trafficking
